Paper32152607
An open-source drug discovery platform enables ultra-large virtual screens.
Gorgulla C and 14 others. Nature, 2020. Cited by 453 papers, by iCite.
Cite this record
ConductScience Library. An open-source drug discovery platform enables ultra-large virtual screens. Papers, record 32152607. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32152607
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Discovery | Major topic |
| Drug Evaluation, Preclinical | Major topic |
| Molecular Docking Simulation | Major topic |
| Software | Major topic |
| User-Computer Interface | Major topic |
| Access to Information | |
| Automation | |
| Cloud Computing | |
| Computer Simulation | |
| Databases, Chemical | |
| Kelch-Like ECH-Associated Protein 1 | |
| Ligands | |
| Molecular Targeted Therapy | |
| NF-E2-Related Factor 2 | |
| Reproducibility of Results | |
| Thermodynamics |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI150709 | NIAID NIH HHS | United States | R01AI150709 | PubMed | NIH RePORTER |
| R01 GM129026 | NIGMS NIH HHS | United States | R01GM129026 | PubMed | NIH RePORTER |
| R01 AI037581 | NIAID NIH HHS | United States | R01AI037581 | PubMed and NIH | NIH RePORTER |
| CA200913 | NIH HHS | United States | PubMed | PubMed | |
| GM129026 | NIH HHS | United States | PubMed | PubMed | |
| R01 CA200913 | NCI NIH HHS | United States | R01CA200913 | PubMed | NIH RePORTER |
| J 3872 | Austrian Science Fund FWF | Austria | PubMed | PubMed | |
| AI037581 | NIH HHS | United States | R01AI037581 | PubMed and NIH | NIH RePORTER |
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26928437 | Innovation in the pharmaceutical industry: New estimates of R&D costs. | J Health Econ | 2016 | https://conductscience.org/library/papers/26928437 | PubMed |
| 2 | 30728502 | Ultra-large library docking for discovering new chemotypes. | Nature | 2019 | https://conductscience.org/library/papers/30728502 | PubMed |
| 3 | 18304355 | DOVIS: an implementation for high-throughput virtual screening using AutoDock. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/18304355 | PubMed |
| 4 | 18778471 | DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. | Chem Cent J | 2008 | https://conductscience.org/library/papers/18778471 | PubMed |
| 5 | 29133831 | Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration. | Sci Rep | 2017 | https://conductscience.org/library/papers/29133831 | PubMed |
| 6 | 8788213 | The art and practice of structure-based drug design: a molecular modeling perspective. | Med Res Rev | 1996 | https://conductscience.org/library/papers/8788213 | PubMed |
| 7 | 28790194 | Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress. | J Pharmacol Exp Ther | 2017 | https://conductscience.org/library/papers/28790194 | PubMed |
| 8 | 29750408 | Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases. | J Med Chem | 2018 | https://conductscience.org/library/papers/29750408 | PubMed |
| 9 | 27031670 | Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery. | J Med Chem | 2016 | https://conductscience.org/library/papers/27031670 | PubMed |
| 10 | 30610225 | Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30610225 | PubMed |
| 11 | 26479676 | ZINC 15--Ligand Discovery for Everyone. | J Chem Inf Model | 2015 | https://conductscience.org/library/papers/26479676 | PubMed |
| 12 | 19499576 | AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. | J Comput Chem | 2010 | https://conductscience.org/library/papers/19499576 | PubMed |
| 13 | 25717194 | Fast, accurate, and reliable molecular docking with QuickVina 2. | Bioinformatics | 2015 | https://conductscience.org/library/papers/25717194 | PubMed |
| 14 | 23379370 | Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/23379370 | PubMed |
| 15 | 26629955 | AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/26629955 | PubMed |
| 16 | 27195023 | AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina. | J Cheminform | 2016 | https://conductscience.org/library/papers/27195023 | PubMed |
| 17 | 26744922 | Vina-Carb: Improving Glycosidic Angles during Carbohydrate Docking. | J Chem Theory Comput | 2016 | https://conductscience.org/library/papers/26744922 | PubMed |
| 18 | 29606412 | Ensemble Docking in Drug Discovery. | Biophys J | 2018 | https://conductscience.org/library/papers/29606412 | PubMed |
| 19 | 23351099 | Consensus docking: improving the reliability of docking in a virtual screening context. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/23351099 | PubMed |
| 20 | 23647822 | Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. | Bioorg Med Chem | 2013 | https://conductscience.org/library/papers/23647822 | PubMed |
Cited by288
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 453 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943275 | Drugging the Undruggable in Oncology: Structural Computation, Machine Learning, and Generative AI for Historically Intractable Targets. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943275 | PubMed |
| 42894001 | Structure based discovery of antipsychotic-like TAAR1 agonists. | Nat Commun | 2026 | https://conductscience.org/library/papers/42894001 | PubMed |
| 42870399 | Representation-aware conformal prediction for reliable uncertainty quantification in drug-target affinity. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42870399 | PubMed |
| 42862171 | Large-scale prospective evaluation of co-folding across hundreds of Mac1-ligand complexes and three virtual screens. | Elife | 2026 | https://conductscience.org/library/papers/42862171 | PubMed |
| 42741636 | Molecular Striptease of a Thiadiazolopyrimidine Hit Yields a Streamlined, Artifact-Free NADPH Mimic for NOX Inhibition. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/42741636 | PubMed |
| 42706738 | SMILES2Docking: An Open-Source Desktop Workflow for Ligand Ionization, Stereochemistry-Aware Preparation and Semi-Empirical 3D Refinement. | Mol Inform | 2026 | https://conductscience.org/library/papers/42706738 | PubMed |
| 42686980 | Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42686980 | PubMed |
| 42686903 | Structure and operating principles of a monkeypox virus replisome. | Nature | 2026 | https://conductscience.org/library/papers/42686903 | PubMed |
| 42686876 | Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42686876 | PubMed |
| 42680826 | AI-enhanced adaptive virtual screening of large libraries for ligand discovery. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42680826 | PubMed |
| 42666875 | Chemical Distance-Based Acceleration of Large Library Docking with ChemSTEP. | ACS Cent Sci | 2026 | https://conductscience.org/library/papers/42666875 | PubMed |
| 42640361 | AI-driven drug design: a comprehensive review. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42640361 | PubMed |
| 42629474 | Siteomix: a PyMOL plugin for the detection, alignment, and similarity analysis of protein‒ligand binding sites. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42629474 | PubMed |
| 42629463 | Computational identification of potential VEGFR2 inhibitors using integrated pharmacophore modeling, QSAR analysis, molecular docking, dynamics simulation, and virtual screening followed by in vitro bioassays. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42629463 | PubMed |
| 42601409 | New paradigm of q-CAR drug development targeting disease-specific protein conformations. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42601409 | PubMed |
| 42599595 | Targeting WEE1 kinase: an integrated machine learning-cheminformatics framework for ultra-large-scale virtual screening and novel inhibitor discovery. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42599595 | PubMed |
| 42589321 | SurroDock: A Deep Learning Surrogate for Accelerated Pre-Docking Ligand Prioritization in Structure-Based Virtual Screening. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589321 | PubMed |
| 42584520 | Multimodal deep learning with a joint uncertainty quantification scheme for drug-target interaction prediction. | Mol Divers | 2026 | https://conductscience.org/library/papers/42584520 | PubMed |
| 42540267 | The Potential of AI-Driven High-Content Imaging in Drug Discovery. | ACS Omega | 2026 | https://conductscience.org/library/papers/42540267 | PubMed |
| 42481749 | Rapid and energy-efficient ultra-large library screening for drug discovery on a SpiNNaker2 neuromorphic chip. | Commun Chem | 2026 | https://conductscience.org/library/papers/42481749 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32152607
GET https://conductscience.org/api/papers/v1/32152607/references?page=2